While DACH1 usually functions as a tumour suppressor in renal cancer [10], lung adenocarcinoma [11], prostate cancer [12] and breast cancer [8], inhibiting biological processes such as cell growth or promoting apoptosis, mainly through the inhibition of cell-cycle proteins, its role in CRC seems to be different [13]. This evidence concerns the gene DACH1 and colorectal carcinoma.